Skip to main content
Signal8

SEARS SAMUEL P JR

SEC insider (Form 3/4/5 filer). CIK 0001238483. Director at Inhibitor Therapeutics, Inc. (INTI). 2 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in TAMPA, FL.

Companies SEARS SAMUEL P JR has filed insider reports for

  • Inhibitor Therapeutics, Inc. (INTI): Director
SEARS SAMUEL P JR profile photo

SEARS SAMUEL P JR

CIK: 0001238483

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Inhibitor Therapeutics, Inc. logo
INTI

Inhibitor Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Inhibitor Therapeutics, Inc. logo
    INTI

    Inhibitor Therapeutics, Inc.

    May 4, 2026
    Award
    Direct
    50K shares-
  • Inhibitor Therapeutics, Inc. logo
    INTI

    Inhibitor Therapeutics, Inc.

    Apr 1, 2025
    Award
    Direct
    50K shares-

1-2 of 2